Celltrion

CELLTRION is a representative international comprehensive biotechnology enterprise in South Korea. It has pioneered an entirely new industry sector called "antibody biosimilars" in the pharmaceutical field, which was once considered a "barren land." CELLTRION, having forged paths untrodden by others and achieved brilliant results, will gradually grow into a global biotechnology enterprise through unique business strategies such as chemical drug and new drug development, as well as U-healthcare platform initiatives. As a leading force in South Korea's pharmaceutical industry, Celltrion launched the world’s first "antibody biosimilar" from a country where the pharmaceutical industry was relatively underdeveloped, achieving what was once thought impossible. The company has blazed trails in numerous uncharted territories, achieved remarkable success, and plans to continue its growth as a global biopharmaceutical company, adopting distinctive approaches in small molecule drugs, new ventures, and ubiquitous healthcare platform businesses.